Dhara Chaudhari, MD
Gastroenterology · Johnson City, TNNPI 1679879092
Payments from drug & device makers
Across 141 payments — averaging $19.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Boston Scientific$607
- Johnson & Johnson$377
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$215
- Bristol Myers Squibb$136
- AstraZeneca$68
- plus $108 from 4 others
What the payments were for
- Travel & lodging$60722%
- Food & beverage$2,11276%
- Education$682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 83 | $1,277 |
| Boston Scientific | 2 | $607 |
| Johnson & Johnson | 25 | $377 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $215 |
| Bristol Myers Squibb | 10 | $136 |
| AstraZeneca | 1 | $68 |
| Enterra Medical, Inc. | 1 | $33 |
| Mauna Kea Technologies, Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Gilead | 1 | $21 |
How this compares
$2,787 in reported general payments places this provider in the 45th percentile of 336 gastroenterology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 86 | $5,063 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 31 | $5,051 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 166 | $2,497 |
| Omeprazole | 123 | $2,249 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 93 | $1,436 |
| Colestipol Hcl | 14 | $1,287 |
| Esomeprazole Magnesium | 13 | $506 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 34 | $501 |
| Pantoprazole Sodium | 39 | $327 |
| Dicyclomine Hcl | 30 | $273 |
| Ondansetron OdtOndansetron | 12 | $247 |
| Metronidazole | 12 | $121 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Johnson City
- Chakradhar ReddyJohnson City$884K
- Ziad YounesGermantown$15.6M
- Robert HerringNashville$3.2M
- Dawn Borromeo BeaulieuNashville$2.1M
- David SchwartzNashville$1.4M
- Kevin FinneganHermitage$1.4M
- Baldeep PablaNashville$1.2M
- Sara HorstNashville$1.2M
- Michael PoraykoNashville$870K
- Saras SharmaNashville$870K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.